How often does ArriVent BioPharma move more than the options market prices?

0 of the last 6 reports moved at least as far as the implied move.

AVBPNasdaqPharmaceutical Preparations

ArriVent BioPharma, Inc. (AVBP) earnings date, market-implied expected move, and options open interest by expiry

13.11

−0.24 · −1.80%

post 13.11 +0.01%

Closed16:00 ET

Open13.85Volume1.2MMkt cap$619.8M

Day13.11 – 13.880%52-wk11.36 – 35.837%

AVBP

ArriVent BioPharma, Inc.

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

No implied move.

Expected move

Inputs

Next report

Nov 9

before open · in 5 days

est.Q3 FY26

Calendar

Next report

Last report

−4.64%

vs ±16.3% implied · ×0.29

shaded = implied · ▲▼ = realized

Aug 12 '26 · confirmed

Implied vs realized

Largest filed tie

—

Supply chain

Largest filed tie

13F top-10 QoQ

+5.08%

shares held · 10 largest managers

13F · Jun 30 '26127d lag

158 managers

Top fund weight

0.28%

AVBP weight · XBI

N-PORTJun 30 '26

4 funds

Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied

ArriVent BioPharma (AVBP) is expected to report on Nov 9 before open (estimated date).

Implied vs realized

8 reports

0 of 6≥ implied

avg implied: ±20.1%
avg realized: ±3.2%

Nov 14 '24Nov 14 '24confirmed—▼−11.86%—

Mar 3 '25Mar 3 '25confirmed—▼−6.69%—

May 12 '25May 12 '25confirmed±21.4%▼−0.79%×0.04

Aug 11 '25Aug 11 '25confirmed±24.7%▼−3.34%×0.14

Nov 10 '25Nov 10 '25confirmed±21.0%▲+3.08%×0.15

Q1 FY26Mar 5 '26confirmed±25.8%▼−7.21%×0.28

May 11 '26May 11 '26confirmed±11.3%▼−0.17%×0.01

Q2 FY26Aug 12 '26confirmed±16.3%▼−4.64%×0.29

quarterimplied−30%0+30%realized×

Q2 FY26±16.3%▼−4.64%×0.29

May '26±11.3%

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Implied vs realized

Positioning

OI · 3 expiries · Nov 3 close

0.42OI · 3 expiries · Nov 3 closeP/C open interest · Nov 20 · first expiry after the report

PUTS · chgexpiry · days · P/CCALLS · chgP/C

1,588+52%Nov 2016d3,7540%

190+1%Jan 1572d0.092,0540%0.09

181+36%Apr 16163d1.9593+19%1.95

ExpiryPutsCallsP/C

Nov 2016d1,588+52%3,7540%0.42

Jan 1572d190+1%2,0540%0.09

Apr 16163d181+36%93+19%1.95

Hatched = puts · solid = calls · bars scaled per expiry · chg = OI vs prior sessionSource: options EOD

Positioning

Linked exposure

No implied move.

Linked exposure

Revenue flow

No filed income statement.

Revenue flow

Intraday

15m bars

Hatch = extended hours · ▯ up · ▮ downSource: market data · 16:00 ET

Intraday

Event sensitivity

CPROF ×1.26· ±3.3% vs ±2.6% · 12 releases

eventrelease day|move|up · n×base

CPROFcorporate profits±3.3%7 of 12×1.26

NFPjobs report±3.1%4 of 10×1.18

CPIconsumer prices±2.7%4 of 10×1.03

GDPgross domestic product±2.4%10 of 19×0.93

PCEpersonal income & outlays±2.2%11 of 19×0.86

PPIproducer prices±2.2%3 of 10×0.85

FOMCrate decision±1.9%9 of 22×0.73

Bar = avg |move| to ±4% · tick = ±2.6% avg day · ×base = |move| ÷ ±2.6% · min 6 releases

Earnings history

EPS -1.05 · consensus —

Quarter	Reported	EPS	Consensus
Q2 FY26	Aug 12 '26 · confirmed	-1.05	—
Q1 FY26	Mar 5 '26 · confirmed	-0.96	—

Source: filed financials

Methodology

ties · implied moves · holdersMethod